Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New frontiers in brachytherapy.

S Nag1

  • 1Division of Radiation Oncology, Arthur G. James Cancer Hospital and Research Institute, Ohio State University, Columbus 43210, USA. nag.1@osu.edu

Surgical Oncology Clinics of North America
|June 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging Synaptic Vesicle Protein SV2C with <sup>18</sup>F-UCB-F: An In Vitro Autoradiography and In Vivo NHP PET Study.

ACS chemical neuroscience·2026
Same author

Nose-to-brain translocation of inhaled ultrafine elongated particles: facts and mysteries.

Frontiers in toxicology·2025
Same author

Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer.

ESMO open·2025
Same author

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer.

ESMO open·2024
Same author

Hypoalbuminaemia as a Marker of Severity of Patients of Community Acquired Pneumonia.

Mymensingh medical journal : MMJ·2023
Same author

Synthesis and biological evaluation of [<sup>18</sup>F]fluorovinpocetine, a potential PET radioligand for TSPO imaging.

Bioorganic & medicinal chemistry letters·2019
Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026
Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026
See all related articles

Brachytherapy delivers high radiation doses directly to tumors, improving cancer cell kill while sparing healthy tissues. Modern techniques have significantly reduced risks for caregivers and patients, increasing its use in prostate and intravascular treatments.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Brachytherapy offers precise, high-dose radiation delivery directly to tumors.
  • Proximity of radiation sources to the tumor maximizes cell kill and spares surrounding normal tissues, reducing morbidity.
  • Historically, radiation exposure risks for caregivers were a significant drawback.

Purpose of the Study:

  • To highlight the advantages of brachytherapy in cancer treatment.
  • To discuss advancements that mitigate previous disadvantages of brachytherapy.
  • To project the increasing application of brachytherapy in specific clinical areas.

Main Methods:

  • Brachytherapy utilizes closely placed or internal radiation sources for targeted tumor irradiation.
  • Low-energy isotopes and remote afterloading techniques minimize radiation exposure risks.

Related Experiment Videos

  • Percutaneous, image-guided brachytherapy overcomes the need for surgical exposure and trauma.

    • Main Results:

    • High dose delivery to the tumor ensures superior cancer cell kill.
    • Sparing of adjacent normal tissues leads to significantly lower treatment-related morbidity.
    • Advancements have effectively addressed historical radiation safety concerns for healthcare providers.

    Conclusions:

    • Brachytherapy is an effective treatment modality offering high tumor-specific doses and reduced normal tissue toxicity.
    • Technological innovations have made brachytherapy safer and less invasive.
    • The use of brachytherapy for prostate cancer and intravascular applications is anticipated to grow.